Skip to content
10-Q

Quarterly Report

Apexigen, Inc.

0000950170-23-022261

← back to feed
Filed
May 15, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2023 · May 5, 2023 24.66M sh
Shares Diluted Q1 2023 · Mar 31, 2023 24.16M sh
Shares Diluted Q1 2023 · Mar 31, 2022 18.08M sh
Capex Q1 2023 · Mar 31, 2023 $0
Capex Q1 2023 · Mar 31, 2022 $43K
Operating Cash Flow Q1 2023 · Mar 31, 2023 −$6.76M
Operating Cash Flow restated Q1 2023 · Mar 31, 2022 −$8.34M
Short Term Investments Q1 2023 · Mar 31, 2023 $0
Short Term Investments Q1 2023 · Dec 31, 2022 $2M
Cash And Equivalents Q1 2023 · Mar 31, 2023 $12.73M
Cash And Equivalents Q1 2023 · Dec 31, 2022 $14.8M
Stockholders Equity Q1 2023 · Mar 31, 2023 $3.11M
Stockholders Equity Q1 2023 · Dec 31, 2022 $6.38M
Stockholders Equity restated Q1 2023 · Mar 31, 2022 $13.43M
Stockholders Equity restated Q1 2023 · Dec 31, 2021 $22M
Current Liabilities Q1 2023 · Mar 31, 2023 $14.45M
Current Liabilities Q1 2023 · Dec 31, 2022 $16.47M
Total Liabilities Q1 2023 · Mar 31, 2023 $14.46M
Total Liabilities Q1 2023 · Dec 31, 2022 $16.48M
Current Assets Q1 2023 · Mar 31, 2023 $16.63M
Current Assets Q1 2023 · Dec 31, 2022 $21.19M
Total Assets Q1 2023 · Mar 31, 2023 $17.58M
Total Assets Q1 2023 · Dec 31, 2022 $22.86M
Eps Diluted Q1 2023 · Mar 31, 2023 −$0.25
Eps Diluted Q1 2023 · Mar 31, 2022 −$0.50
Eps Basic Q1 2023 · Mar 31, 2023 −$0.25
Eps Basic Q1 2023 · Mar 31, 2022 −$0.50
Sga Expense Q1 2023 · Mar 31, 2023 $3.28M
Sga Expense restated Q1 2023 · Mar 31, 2022 $1.99M
Rd Expense Q1 2023 · Mar 31, 2023 $2.94M
Rd Expense Q1 2023 · Mar 31, 2022 $7.11M
Net Income Q1 2023 · Mar 31, 2023 −$6.05M
Net Income restated Q1 2023 · Mar 31, 2022 −$9.04M
Operating Income Q1 2023 · Mar 31, 2023 −$6.22M
Operating Income restated Q1 2023 · Mar 31, 2022 −$9.09M